Lucky Bay Area shoppers: C&T Publishing, an industry leader in the publishing of books and products for quilters and fiber arts markets worldwide, has its headquarters and distribution center in Concord. On Saturday, it will open its warehouse for its annual...

View original here:
C&T Publishing sale in Concord

Seattle author Jayne Ann Krentz's latest "Arcane Society" novel leads off this week's list of titles of local interest.

Read more here:
Local books: A Seattle environmental-activism history, a study of 'design thinking' and a paranormal romance or two

Biotech company Genzyme Inc rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis SA on Monday, setting the stage for a protracted and potentially hostile takeover battle.

See the original post here:
Genzyme rejects Sanofi offer as long battle looms

U.S. biotech group Genzyme rejected an $18.5 billion takeover proposal by French drugmaker Sanofi-Aventis on Monday, setting up what could be a protracted battle.

Read the original:
Genzyme rejects Sanofi offer, long battle looms

U.S. biotech Genzyme broke its five-week silence to reject an $18.5 billion takeover proposal by French drugmaker Sanofi-Aventis on Monday, dismissing it as opportunistic and too low.

See the rest here:
Genzyme breaks silence to rebuff Sanofi

Earlier this summer, Michael Ian Black took to his blog to defend himself against those appalled that the comedian was — gasp! — inserting rare advertisements to his popular Twitter feed.

Originally posted here:
An open mic, in 140-characters or less

There are little more than a dozen residents left in as many wooden homes in this hamlet tucked away from civilisation in eastern Latvia. All are Old Believers, a faith struggling to survive.

See the original post here:
Time takes its toll on Latvia's 'Old Believers'

France's Sanofi-Aventis on Sunday publicly disclosed its $18.5 billion, $69-per-share cash offer for Genzyme Corp in a bid to rouse shareholders after failing to engage the U.S.

Read the original here:
Sanofi makes $18.5 billion Genzyme offer public

France's Sanofi-Aventis on Sunday publicly disclosed its $18.5 billion, $69-per-share cash offer for Genzyme Corp in a bid to rouse shareholders after failing to engage the U.S. biotechnology company in merger talks.

Originally posted here:
Sanofi-Aventis makes $18.5 billion offer for Genzyme

After slashing the listing price on the Frank Lloyd Wright textile=block house in the past two years from $7,733,000 to $4,995,000 and not finding a buyer, Crosby Doe says he's "talking to an international art dealer with Japanese art-collector clients who might be interested in buying the house."

Go here to see the original:
Landmark Frank Lloyd Wright houses languish on the market